REGENXBIO
RGNX
#7519
Rank
C$0.67 B
Marketcap
C$10.27
Share price
-0.28%
Change (1 day)
-38.30%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): C-$4.44

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is C-$4.60. In 2025 the company made an earnings per share (EPS) of C-$5.39 an increase over its 2024 EPS that were of C-$6.61.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.44-17.58%
2025C-$5.39-18.44%
2024C-$6.61
2022C-$9.32-321.09%
2021C$4.22-198.33%
2020C-$4.2915.44%
2019C-$3.71-181.19%
2018C$4.57-229.15%
2017C-$3.543.35%
2016C-$3.435.42%
2015C-$3.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA